Trial Profile
Markers of Efficacy of Xolair (Omalizumab) in Chronic Spontaneous Urticaria
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 09 Jun 2015
Price :
$35
*
At a glance
- Drugs Omalizumab (Primary)
- Indications Urticaria
- Focus Therapeutic Use
- Acronyms U-MEX
- 09 Jun 2015 New trial record